Abstract
The paroxysmal and focal alterations in the electroencephalogram (EEG) of subjects who have never experienced epileptic seizures may be associated with neurodevelopmental disorders in infancy.To determine the true behaviour of the bioelectrical manifestation we have developed a therapeutic protocol with anticonvulsive drugs to enable us to evaluate the degree of clinical improvement along with that of the bioelectrical resolution.Four groups of patients were selected with 10 patients in each group, allocated according to their clinical diagnosis. The study groups were made up of patients suffering from language and speech disorders (LSD), specific learning difficulties (SLD), attention deficit hyperactivity disorder (ADHD), and a fourth group with mixed neuropsychological symptoms (MNS).A linear relation was found between the behaviour of the clinical progress and the electroencephalographic progress in the groups with LSD and ADHD, and to a lesser extent with the MNS and SLD groups. Clinical progress was considered to be successful in three of the 10 children studied in group A (LSD), in one of the 10 in group B (SLD), in two of the ten belonging to group C (ADHD), and in three of the 10 subjects in group D (MNS).The pharmacological treatment of neurodevelopmental disorders, with an abnormal EEG pattern and no seizures, was found to behave favourably in 80% of the cases for the four groups under study. The presence of an EEG-4 pattern, slow focal activity, was indicative of a regular clinical prognosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.